SK Discovery Co.,Ltd. Single Sales/Supply Contract
SAI summary · Not investment advice
SK Discovery's subsidiary SK Plasma signed a KRW 62.7 billion blood plasma product supply contract with Arvatera of Turkey on October 29, 2026.
Contract amount
KRW 62.7 billion
Key facts
- Contract details
- Blood plasma product supply contractProduct supply
- Recent revenue
- KRW 219.0 billionBased on consolidated financial statements at end of 2025
- % of revenue
- 28.64%
- Counterparty
- Arvatera ilac Sanayi ve Ticaret A.S.
- Contract period
- Oct 29, 2026 – Sep 30, 2027
- Contract date
- Oct 29, 2026
- Supply region
- Türkiye
- Payment terms
- Within 60 or 120 days after shipmentNo down payment or advance payment
- Subsidiary
- SK Plasma Co., Ltd.
Commentary
AI commentary · Not investment advice
What happened
SK Discovery's subsidiary SK Plasma Co., Ltd. signed a supply contract for blood plasma products with Arvatera ilac Sanayi ve Ticaret A.S. of Turkey. The contract is worth KRW 62.7 billion and was signed on 2026.10.29. The contract period runs from 2026.10.29 to 2027.09.30, and the supply region is Turkey. The disclosure was received on 2026.10.30.
In the company's terms
Relative to the company, the contract amount equals 28.64% of recent revenue of KRW 219.0 billion. Against market capitalization, the figure is listed as 6.1%. There were 2 disclosures of the same type in the past year, dated 2026.04.03 and 2026.03.24.
What changes for shareholders
The payment terms are within 60 or 120 days after shipment.
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist